Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinar Iyidogan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Biochemistry|March 26, 2008
Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificityPinar Iyidogan, Stefan Lutz
Antiviral Research|June 6, 2012
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tractPinar Iyidogan, Karen S Anderson
Antiviral Chemistry & Chemotherapy|June 8, 2013
Recent findings on the mechanisms involved in tenofovir resistancePinar Iyidogan, Karen S Anderson
Viruses|October 25, 2014
Current perspectives on HIV-1 antiretroviral drug resistancePinar Iyidogan, Karen S Anderson
ACS Medicinal Chemistry Letters|June 6, 2014
Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse TranscriptasePinar Iyidogan, Todd J Sullivan, Mahendra D Chordia, et al.
ACS Sensors|March 1, 2018
Plasmonic Sensor Could Enable Label-Free DNA SequencingArif E Cetin, Pinar Iyidogan, Yuki Hayashi, et al.
Pigment Cell & Melanoma Research|April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitorsCasey G Langdon, Matthew A Held, James T Platt, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2015
A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from CryptosporidiumAnindita Mukerjee, Pinar Iyidogan, Alejandro Castellanos-Gonzalez, et al.
Journal of Medicinal Chemistry|May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategyChristopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biochemistry|March 26, 2008
Systematic exploration of active site mutations on human deoxycytidine kinase substrate specificityPinar Iyidogan, Stefan Lutz
Antiviral Research|June 6, 2012
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tractPinar Iyidogan, Karen S Anderson
Antiviral Chemistry & Chemotherapy|June 8, 2013
Recent findings on the mechanisms involved in tenofovir resistancePinar Iyidogan, Karen S Anderson
Viruses|October 25, 2014
Current perspectives on HIV-1 antiretroviral drug resistancePinar Iyidogan, Karen S Anderson
ACS Medicinal Chemistry Letters|June 6, 2014
Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse TranscriptasePinar Iyidogan, Todd J Sullivan, Mahendra D Chordia, et al.
ACS Sensors|March 1, 2018
Plasmonic Sensor Could Enable Label-Free DNA SequencingArif E Cetin, Pinar Iyidogan, Yuki Hayashi, et al.
Pigment Cell & Melanoma Research|April 10, 2015
The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth of BRAF-mutant melanoma cells in combination with other signaling pathway inhibitorsCasey G Langdon, Matthew A Held, James T Platt, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2015
A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from CryptosporidiumAnindita Mukerjee, Pinar Iyidogan, Alejandro Castellanos-Gonzalez, et al.
Journal of Medicinal Chemistry|May 11, 2013
Bifunctional inhibition of human immunodeficiency virus type 1 reverse transcriptase: mechanism and proof-of-concept as a novel therapeutic design strategyChristopher M Bailey, Todd J Sullivan, Pinar Iyidogan, et al.
Oncotarget|October 21, 2015
SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cellsCasey G Langdon, Norbert Wiedemann, Matthew A Held, et al.
Pageof 2